id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-289188-hf9sh9vs	Salazar, M. R.	EFFECT OF CONVALESCENT PLASMA ON MORTALITY IN PATIENTS WITH COVID-19 PNEUMONIA	2020-10-09		.txt	text/plain	3044	192	47	Logistic regression analysis identified age, ICU admission with and without MV requirement, diabetes and preexistent cardiovascular disease as independent predictors of 28-day mortality, whereas convalescent plasma administration acted as a protective factor. Conclusions Our study suggests that the administration of convalescent plasma in COVID-19 pneumonia admitted to the hospital might be associated with decreased mortality. . https://doi.org/10.1101/2020.10.08.20202606 doi: medRxiv preprint administered early in the course of COVID-19 [14] [15] .Convalescent plasma is currently being evaluated in 126 clinical trials [16] . Accordingly, the objective of the present study is to compare the epidemiological characteristics, outcomes and independent predictors of mortality among patients who received convalescent plasma and those who did not receive it, who were admitted to hospitals in Buenos Aires Province for COVID-19 throughout the pandemic. The main finding of our study was that the administration of convalescent plasma to patients with COVID-19 pneumonia was associated with a decrease of 24.4% in adjusted mortality.	./cache/cord-289188-hf9sh9vs.txt	./txt/cord-289188-hf9sh9vs.txt